OUR PRODUCTS

MOBILE APPS

GENERAL INFO

AGIO

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Agios Pharmaceuticals (AGIO) Earnings Date & Reports

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

AGIO is expected to report earnings to fall 1.04% to -190 cents per share on October 30

Agios Pharmaceuticals AGIO Stock Earnings Reports

Q3'25

Est.

$-1.91

Q2'25

Missed

by $0.12

Q1'25

Beat

by $0.23

Q4'24

Beat

by $0.24

Q3'24

Beat

by $1.00

The last earnings report on July 31 showed earnings per share of -192 cents, missing the estimate of -180 cents. With 130.77K shares outstanding, the current market capitalization sits at 2.13B.

View a ticker or compare two or three

Compare

AGIO

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For AGIO
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. AGIO showed earnings on July 31, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of therapeutics

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

88 Sidney Street

Phone

+1 617 649-8600

Employees

386

Web

https://www.agios.com